Searched for
INVEST IN APY
Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- ETtech interview: AI is a capital game; our fundraise is large for India but quite small in the global context: Sarvam cofoundersIn an interview with ET, Sarvam cofounder Pratyush Kumar said Sarvam — which counts HCLTech, Bessemer Venture Partners, Peak XV, Khosla Ven...
- Hari Menon exits BigBasket; Sarvam cofounder on fresh fundingBigBasket's longtime leader Hari Menon has stepped down as CEO. This and more in today's ETtech Top 5.
- Sarvam: When US slams the door, India begins to find its own openingSarvam AI’s rise to a $1.5 bn valuation after raising $234 mn marks a major milestone for India’s push toward AI sovereignty. The funding c...
- Agentic AI adoption drives stronger governance oversight, risk controlsIndian companies are prioritising local AI rules over international ones. They are focusing on ethics, identity, and privacy as AI adoption...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
- Keshav Reddy's Equal AI raises $30 million in round led by Prosus, Tomales Bay CapitalThe round also saw participation from Think Investments, Valiant Fund, PhonePe founder Sameer Nigam, and Zubin Bharti Mittal, among others....
- Liqvd Asia bets on AI, acquisitions to fuel next phase of growth ahead of SME IPOCreative-led digital agency Liqvd Asia is leveraging artificial intelligence and acquisitions for growth, aiming to provide faster, persona...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- Govt to tap AI for mapping supply chains and investment clustersIndia's upcoming Statistical Business Register (SBR) will leverage AI and analytics to map supply chains, identify investment clusters, and...
- The hidden shortage threatening the AI boom - how to prepare for what comes nextAI data center power shortage: The AI boom's next frontier is electricity, shifting focus from models and GPUs to the immense power needed ...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- Watch: Anthropic's free Claude workshop that teaches 40 prompting techniques from the team behind the AIAnthropic has released a free 24-minute workshop featuring its Applied AI team, offering 40 prompting techniques to enhance Claude's output...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- 20 months of bearish markets: One additional letter that tells you which 'cheap' stocks are actually cheapMost investors live by one ratio. That ratio that tells them all they want to know – or should one say all they want to hear? They open a s...
- True North buys 25% stake in pharma co EmbioPrivate equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients fo...
Load More
